Nitric Acid

Nitric Acid

SCHEMBL8957413

O=[N+]([O-])O.O=[N+]([O-])O.OCC1CCCCC1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
GSR P00390 2/20 0.36
EPHX1 P07099 2/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
ALOX5 P09917 1/20 0.33
POLB P06746 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ESR1 P03372 5/20 0.32
ESR2 Q92731 5/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32
ADH4 P08319 1/20 0.32
ADH7 P40394 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL8957377 1.00 CA5A (0.38) CA5ACA5BGSREPHX1HPGD
Nitric Acid SCHEMBL9874935 0.87 CA5A (0.44) CA5ACA5BGSRALDH1A1ESR1
Nitric Acid SCHEMBL8957431 0.82 HPGD (0.37) CA5ACA5BGSREPHX1HPGD
Cyclopentane SCHEMBL9063672 0.82 ESR1 (0.40) EPHX1HPGDKMT2AALOX5ESR1
SCHEMBL20903 0.82
SCHEMBL738125 0.82 ESR1 (0.40) EPHX1HPGDKMT2AALOX5ESR1
SCHEMBL4986081 0.82 ESR1 (0.40) EPHX1HPGDKMT2AALOX5ESR1
SCHEMBL13646378 0.82 ESR1 (0.40) EPHX1HPGDKMT2AALOX5ESR1
SCHEMBL16260127 0.82 ESR1 (0.40) EPHX1HPGDKMT2AALOX5ESR1
SCHEMBL14306984 0.82 ESR1 (0.40) EPHX1HPGDKMT2AALOX5ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed